Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T15385 |
Glibornuride
|
Potassium Channel | Membrane transporter/Ion channel |
Glibornuride 是对 ATP 敏感的 K+通道 (KATP 通道) 阻滞剂,pKi 为 5.75。Glibornuride 显示抗糖尿病活性。 | |||
T29457L |
5-Hydroxydecanoate sodium
|
Potassium Channel | Membrane transporter/Ion channel |
5-Hydroxydecanoate sodium 是一种选择性 ATP 敏感的 K+ (KATP) 通道阻滞剂,IC50 约为 30 μM。 它是线粒体外膜酰基辅酶A 合成酶的底物,具有抗氧化性。 | |||
T2404 |
Vonoprazan fumarate
富马酸沃诺拉赞,TAK-438 |
ATPase | Membrane transporter/Ion channel |
Vonoprazan fumarate (TAK-438) 是一种新型 P-CAB(钾竞争性酸阻滞剂),可可逆地抑制 H+/K+、ATP 酶。 | |||
T17030 |
Tegoprazan
|
ATPase; Proton pump | Membrane transporter/Ion channel |
Tegoprazan 是一种口服有效的、高选择性胃 H+/K+-ATP 酶 (H+/K+-ATPase) 抑制剂,能够控制胃酸分泌和运动,在体外检测的对猪、犬、人的 H+/K+-ATP 酶的 IC50为0.29-0.52 μM。 | |||
T2024 |
A-803467
A 803467,A803467 |
Sodium Channel | Membrane transporter/Ion channel |
A-803467 是有效的、选择性的河豚毒素不敏感型Nav1.8 钠通道阻断剂 。它在炎症性疼痛和神经性疼痛模型中有缓解疼痛作用。它通过与 ATP-binding cassette subfamily G member 2 (ABCG2) 转运蛋白的相互作用,增强了传统抗癌物的化疗敏感性。 | |||
T15386 | Glisoxepide | Others | Others |
Glisoxepide is a sulphonamide derivative and is an orally available nonselective K(ATP) channel blocker. It has antihyperglycemic activity and cardiovascular regulation effect. | |||
T70801 |
ZM-181037
|
||
ZM-181037 is an ATP-sensitive potassium channel-blocker and a eukalemic diuretic. | |||
T11243 |
Ethyl tosylcarbamate
|
Others | Others |
Gliclazide is a whole-cell beta-cell ATP-sensitive potassium currents blocker with an IC50 of 184 nM. Ethyl tosylcarbamate is an intermediate in the synthesis of Gliclazide (G409877). | |||
T28977 |
Tilisolol HCl
Tilisolol, trade name Selecal,N 696,N-696,N696 |
||
Tilisolol is a nonselective blocker of beta-adrenergic. Tilisolol hydrochloride dilates coronary arteries through an ATP-sensitive K(+)-channel opening mechanism in dogs. | |||
T63330 |
Clamikalant sodium
|
||
Clamikalant sodium 是非选择性的、 ATP 敏感性的钾 (KATP) 通道阻滞剂,能够用于研究心律不齐。 | |||
T41204 |
TAT-Gap19(I130A)
TAT-Gap19(I130A) |
||
TAT-Gap19(I130A) is a control peptide for TAT-Gap19, a Cx43 hemichannel blocker. TAT-Gap19(I130A) consists of TAT-GAP19 with a I130A amino acid residue change at a key residue for GAP19 activity. In C6 glioma cells expression Cx43, TAT-GAP19(1130A) does not inhibit [Ca2+]i-triggered ATP release at 200 μM. TAT-Gap19(I130A) is cell permeable. | |||
T11731L |
JTV-519 Formate
JTV-519 Formate (145903-06-6 Free base) |
Others; Calcium Channel | Membrane transporter/Ion channel; Metabolism; Others |
JTV-519 Formate 是一种 Ca2+ 依赖性的肌质网 Ca2+ 刺激的 ATP 酶 (SERCA) 阻断剂,同时也是横纹肌中兰尼碱受体 (ryanodine receptors) 的部分激动剂。JTV-519 Formate 显示出抗心律失常作用,是一种心脏保护剂。 |